Balloon catheter injury abolishes phenylephrine-induced relaxation in the rat contralateral carotid

Br J Pharmacol. 2011 Jun;163(4):770-81. doi: 10.1111/j.1476-5381.2011.01275.x.

Abstract

Background and purpose: The consequences of compensatory responses to balloon catheter injury in rat carotid artery, on phenylephrine-induced relaxation and contraction in the contralateral carotid artery were studied.

Experimental approach: Relaxation and contraction concentration-response curves for phenylephrine were obtained for contralateral carotid arteries in the presence of indomethacin (COX inhibitor), SC560 (COX-1 inhibitor), SC236 (COX-2 inhibitor) or 4-hydroxytetramethyl-L-piperidine-1-oxyl (tempol; superoxide dismutase mimetic). Reactive oxygen species were measured in carotid artery endothelial cells fluorimetrically with dihydroethidium.

Key results: Phenylephrine-induced relaxation was abolished in contralateral carotid arteries from operated rats (E(max) = 0.01 ± 0.004 g) in relation to control (E(max) = 0.18 ± 0.005 g). Phenylephrine-induced contractions were increased in contralateral arteries (E(max) = 0.54 ± 0.009 g) in relation to control (E(max) = 0.38 ± 0.014 g). SC236 restored phenylephrine-induced relaxation (E(max) = 0.17 ± 0.004 g) and contraction (E(max) = 0.34 ± 0.018 g) in contralateral arteries. Tempol restored phenylephrine-induced relaxation (E(max) = 0.19 ± 0.012 g) and contraction (E(max) = 0.42 ± 0.014 g) in contralateral arteries, while apocynin did not alter either relaxation (E(max) = 0.01 ± 0.004 g) or contraction (E(max) = 0.54 ± 0.009 g). Dihydroethidium fluorescence was increased in contralateral samples (18 882 ± 435 U) in relation to control (10 455 ± 303 U). SC236 reduced the fluorescence in contralateral samples (8250 ± 365 U).

Conclusions and implications: Balloon catheter injury abolished phenylephrine-induced relaxation and increased phenylephrine-induced contraction in contralateral carotid arteries, through O(2) (-) derived from COX-2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angioplasty, Balloon, Coronary / adverse effects*
  • Animals
  • Carotid Arteries / drug effects*
  • Carotid Arteries / metabolism
  • Carotid Arteries / physiology
  • Carotid Artery Injuries / metabolism
  • Carotid Artery Injuries / physiopathology*
  • Cyclic N-Oxides / pharmacology
  • Cyclooxygenase Inhibitors / pharmacology
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / injuries
  • Indomethacin / pharmacology
  • Male
  • Muscle Contraction / drug effects*
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / metabolism
  • NADP / metabolism
  • NADPH Oxidases / metabolism
  • Oxygen / metabolism
  • Phenylephrine / pharmacology*
  • Prostaglandin-Endoperoxide Synthases / metabolism
  • Pyrazoles / pharmacology
  • Rats
  • Rats, Wistar
  • Reactive Oxygen Species / metabolism
  • Spin Labels
  • Sulfonamides / pharmacology
  • Vasodilation / drug effects*

Substances

  • 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
  • Cyclic N-Oxides
  • Cyclooxygenase Inhibitors
  • Pyrazoles
  • Reactive Oxygen Species
  • SC 560
  • Spin Labels
  • Sulfonamides
  • Phenylephrine
  • NADP
  • Prostaglandin-Endoperoxide Synthases
  • NADPH Oxidases
  • Oxygen
  • tempol
  • Indomethacin